The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Paraneoplastic limbic encephalitis: neurological symptoms, immunological findings and tumour association in 50 patients
Abstract
Paraneoplastic limbic encephalitis (PLE) is a rare disorder characterized by personality changes, irritability, depression, seizures, memory loss and sometimes dementia. The diagnosis is difficult because clinical markers are often lacking, and symptoms usually precede the diagnosis of cancer or mimic other complications. The frequency of antineuronal antibodies in patients with PLE has not been investigated. We examined the neurological symptoms and the causal tumours in 50 patients with PLE to determine the utility of paraneoplastic antibodies and other tests. The diagnosis of PLE required neuropathological examination or the presence of the four following criteria: (i) a compatible clinical picture; (ii) an interval of <4 years between the development of neurological symptoms and tumour diagnosis; (iii) exclusion of other neuro-oncological complications; and (iv) at least one of the following: CSF with inflammatory changes but negative cytology; MRI demonstrating temporal lobe abnormalities; EEG showing epileptic activity in the temporal lobes. Of 1047 patients with neurological symptoms, whose sera or CSF were examined for paraneoplastic antibodies, 79 had the presumptive diagnosis of limbic encephalitis, dementia, cognitive dysfunction, or confusion. Fifty of these patients fulfilled our criteria for PLE. Pathological confirmation was obtained in 12 patients. The commonly associated neoplasms were of the lung (50%), testis (20%) and breast (8%). Neurological symptoms preceded the cancer diagnosis in 60% of patients (by a median of 3.5 months). Twenty-five of 44 (57%) patients with MRI studies had signal abnormalities in the limbic system. Thirty (60%) patients had antineuronal antibodies (18 anti-Hu, 10 anti-Ta, 2 anti-Ma), and 20 were antibody-negative or had uncharacterized antibodies (n = 4). The combination of symptoms, MRI findings and paraneoplastic antibodies established the diagnosis of PLE in 78% of the patients. Patients with anti-Hu antibodies usually had small-cell lung cancer (94%), multifocal neurological symptoms (78%) and a poor neurological outcome. Patients with anti-Ta (also called anti-Ma2) antibodies were young men with testicular tumours (100%), frequent hypothalamic involvement (70%) and a poor neurological outcome. In the group of patients without anti-Hu or anti-Ta antibodies, the tumour distribution was diverse, with cancer of the lung the most common (36%); 57% had positive MRI. Fifteen of 34 (44%) patients with a median follow-up of 8 months showed neurological improvement. Treatment of the tumour appeared to have more effect on the neurological outcome than the use of immune modulation. Improvement was observed in 38% of anti-Hu patients, 30% of anti-Ta patients and 64% of patients without these antibodies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Oosterhuis, H. (1997) · Cited by 2,397
Cabot, R. C., Scully, R. E., Mark, E. J., McNeely, W. F., McNeely, B. U., Harris, W. H., & Rosenberg, A. E. (1990) · New England Journal of Medicine · doi:10.1056/nejm199008233230808 · Cited by 896
Regulation of Class I MHC Gene Expression in the Developing and Mature CNS by Neural Activity
Corriveau, R. A., Huh, G. S., & Shatz, C. J. (1998) · Neuron · doi:10.1016/s0896-6273(00)80562-0 · Cited by 548
Lucchinetti, C. F., Kimmel, D. W., & Lennon, V. A. (1998) · Neurology · doi:10.1212/wnl.50.3.652 · Cited by 499
“LIMBIC ENCEPHALITIS” AND ITS ASSOCIATION WITH CARCINOMA
CORSELLIS, J. A. N., GOLDBERG, G. J., & NORTON, A. R. (1968) · Brain · doi:10.1093/brain/91.3.481 · Cited by 491
Induction of MHC Class I Genes in Neurons
Neumann, H., Cavalié, A., Jenne, D. E., & Wekerle, H. (1995) · Science · doi:10.1126/science.7624779 · Cited by 449
Voltz, R., Gultekin, S. H., Rosenfeld, M. R., Gerstner, E., Eichen, J., Posner, J. B., & Dalmau, J. (1999) · New England Journal of Medicine · doi:10.1056/nejm199906103402303 · Cited by 379
Self-citationSpiegel, D. (1996) · British Journal of Psychiatry · doi:10.1192/s0007125000298486 · Cited by 303
Neumann, H., Schmidt, H., Cavalié, A., Jenne, D., & Wekerle, H. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.2.305 · Cited by 288
SUBACUTE ENCEPHALITIS OF LATER ADULT LIFE. MAINLY AFFECTING THE LIMBIC AREAS
BRIERLEY, J. B., CORSELLIS, J. A. N., HIERONS, R., & NEVIN, S. (1960) · Brain · doi:10.1093/brain/83.3.357 · Cited by 285
Cited by
A clinical approach to diagnosis of autoimmune encephalitis
Graus, F., Titulaer, M. J., Balu, R., Benseler, S., Bien, C. G., Cellucci, T., Cortese, I., Dale, R. C., Gelfand, J. M., Geschwind, M., et al. (2016) · The Lancet Neurology · doi:10.1016/s1474-4422(15)00401-9 · Cited by 4,516
Paraneoplastic anti– N ‐methyl‐ D ‐aspartate receptor encephalitis associated with ovarian teratoma
Dalmau, J., Tüzün, E., Wu, H., Masjuan, J., Rossi, J. E., Voloschin, A., Baehring, J. M., Shimazaki, H., Koide, R., King, D., et al. (2007) · Annals of Neurology · doi:10.1002/ana.21050 · Cited by 2,492
Recommended diagnostic criteria for paraneoplastic neurological syndromes
Graus, F. (2004) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2003.034447 · Cited by 1,610
Swann, J. B., & Smyth, M. J. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31405 · Cited by 1,447
Lai, M., Huijbers, M. G., Lancaster, E., Graus, F., Bataller, L., Balice-Gordon, R., Cowell, J. K., & Dalmau, J. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70137-x · Cited by 1,361
van Meerbeeck, J. P., Fennell, D. A., & De Ruysscher, D. K. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60165-7 · Cited by 1,237
Paraneoplastic Syndromes Involving the Nervous System
Darnell, R. B., & Posner, J. B. (2003) · New England Journal of Medicine · doi:10.1056/nejmra023009 · Cited by 1,062
Vincent, A., Buckley, C., Schott, J. M., Baker, I., Dewar, B., Detert, N., Clover, L., Parkinson, A., Bien, C. G., Omer, S., et al. (2004) · Brain · doi:10.1093/brain/awh077 · Cited by 1,038
Paraneoplastic syndromes of the CNS
Dalmau, J., & Rosenfeld, M. R. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70060-7 · Cited by 873
AMPA receptor antibodies in limbic encephalitis alter synaptic receptor location
Lai, M., Hughes, E. G., Peng, X., Zhou, L., Gleichman, A. J., Shu, H., Matà, S., Kremens, D., Vitaliani, R., Geschwind, M. D., et al. (2009) · Annals of Neurology · doi:10.1002/ana.21589 · Cited by 813
Clinical analysis of anti-Ma2-associated encephalitis
Dalmau, J. (2004) · Brain · doi:10.1093/brain/awh203 · Cited by 771
Updated Diagnostic Criteria for Paraneoplastic Neurologic Syndromes
Graus, F., Vogrig, A., Muñiz-Castrillo, S., Antoine, J.-C. G., Desestret, V., Dubey, D., Giometto, B., Irani, S. R., Joubert, B., Leypoldt, F., et al. (2021) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000001014 · Cited by 759
Saiz, A., Blanco, Y., Sabater, L., González, F., Bataller, L., Casamitjana, R., Ramió-Torrentà, L., & Graus, F. (2008) · Brain · doi:10.1093/brain/awn183 · Cited by 623
Paraneoplastic encephalitis, psychiatric symptoms, and hypoventilation in ovarian teratoma
Vitaliani, R., Mason, W., Ances, B., Zwerdling, T., Jiang, Z., & Dalmau, J. (2005) · Annals of Neurology · doi:10.1002/ana.20614 · Cited by 604
Screening for tumours in paraneoplastic syndromes: report of an EFNS Task Force
Titulaer, M. J., Soffietti, R., Dalmau, J., Gilhus, N. E., Giometto, B., Graus, F., Grisold, W., Honnorat, J., Sillevis Smitt, P. A. E., Tanasescu, R., et al. (2011) · European Journal of Neurology · doi:10.1111/j.1468-1331.2010.03220.x · Cited by 526
Antibodies to glutamic acid decarboxylase define a form of limbic encephalitis
Malter, M. P., Helmstaedter, C., Urbach, H., Vincent, A., & Bien, C. G. (2010) · Annals of Neurology · doi:10.1002/ana.21917 · Cited by 514
Treatment-responsive limbic encephalitis identified by neuropil antibodies: MRI and PET correlates
Ances, B. M., Vitaliani, R., Taylor, R. A., Liebeskind, D. S., Voloschin, A., Houghton, D. J., Galetta, S. L., Dichter, M., Alavi, A., Rosenfeld, M. R., et al. (2005) · Brain · doi:10.1093/brain/awh526 · Cited by 488
Limbic Encephalitis and Variants: Classification, Diagnosis and Treatment
Tüzün, E., & Dalmau, J. (2007) · The Neurologist · doi:10.1097/nrl.0b013e31813e34a5 · Cited by 478
Kalemkerian, G. P., Akerley, W., Bogner, P., Borghaei, H., Chow, L. Q., Downey, R. J., Gandhi, L., Ganti, A. K. P., Govindan, R., Grecula, J. C., et al. (2013) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2013.0011 · Cited by 436
Leypoldt, F., Armangue, T., & Dalmau, J. (2015) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12553 · Cited by 416
Potentially reversible autoimmune limbic encephalitis with neuronal potassium channel antibody
Thieben, M. J., Lennon, V. A., Boeve, B. F., Aksamit, A. J., Keegan, M., & Vernino, S. (2004) · Neurology · doi:10.1212/01.wnl.0000122648.19196.02 · Cited by 394
Paraneoplastic Neurologic Syndrome in the PNS Euronetwork Database: A European Study From 20 Centers
Giometto, B. (2010) · Archives of Neurology · doi:10.1001/archneurol.2009.341 · Cited by 373
Paraneoplastic neurological syndromes
Honnorat, J., & Antoine, J.-C. (2007) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-2-22 · Cited by 357
Geschwind, M. D., Shu, H., Haman, A., Sejvar, J. J., & Miller, B. L. (2008) · Annals of Neurology · doi:10.1002/ana.21430 · Cited by 323
Autoimmune Encephalitis: Pathophysiology and Imaging Review of an Overlooked Diagnosis
Kelley, B. P., Patel, S. C., Marin, H. L., Corrigan, J. J., Mitsias, P. D., & Griffith, B. (2017) · American Journal of Neuroradiology · doi:10.3174/ajnr.a5086 · Cited by 310
Zuliani, L., Graus, F., Giometto, B., Bien, C., & Vincent, A. (2012) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2011-301237 · Cited by 293
A patient with encephalitis associated with NMDA receptor antibodies
Sansing, L. H., Tüzün, E., Ko, M. W., Baccon, J., Lynch, D. R., & Dalmau, J. (2007) · Nature Clinical Practice Neurology · doi:10.1038/ncpneuro0493 · Cited by 291
Molecular and clinical diversity in paraneoplastic immunity to Ma proteins
Rosenfeld, M. R., Eichen, J. G., Wade, D. F., Posner, J. B., & Dalmau, J. (2001) · Annals of Neurology · doi:10.1002/ana.1288 · Cited by 291
Anti-NMDA receptor encephalitis: report of ten cases and comparison with viral encephalitis
Gable, M. S., Gavali, S., Radner, A., Tilley, D. H., Lee, B., Dyner, L., Collins, A., Dengel, A., Dalmau, J., & Glaser, C. A. (2009) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-009-0799-0 · Cited by 291
Post-transplant acute limbic encephalitis: Clinical features and relationship to HHV6
Seeley, W. W., Marty, F. M., Holmes, T. M., Upchurch, K., Soiffer, R. J., Antin, J. H., Baden, L. R., & Bromfield, E. B. (2007) · Neurology · doi:10.1212/01.wnl.0000265591.10200.d7 · Cited by 284
Paraneoplastic neurological syndromes in the era of immune-checkpoint inhibitors
Graus, F., & Dalmau, J. (2019) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-019-0194-4 · Cited by 276
Imaging of autoimmune encephalitis – Relevance for clinical practice and hippocampal function
Heine, J., Prüss, H., Bartsch, T., Ploner, C. J., Paul, F., & Finke, C. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.05.037 · Cited by 272
GABA B receptor antibodies in limbic encephalitis and anti-GAD–associated neurologic disorders
Boronat, A., Sabater, L., Saiz, A., Dalmau, J., & Graus, F. (2011) · Neurology · doi:10.1212/wnl.0b013e31820e7b8d · Cited by 271
Treatment strategies for autoimmune encephalitis
Shin, Y.-W., Lee, S.-T., Park, K.-I., Jung, K.-H., Jung, K.-Y., Lee, S. K., & Chu, K. (2018) · Therapeutic Advances in Neurological Disorders · doi:10.1177/1756285617722347 · Cited by 266
Lawn, N. D., Westmoreland, B. F., Kiely, M. J., Lennon, V. A., & Vernino, S. (2003) · Mayo Clinic Proceedings · doi:10.4065/78.11.1363 · Cited by 266
Anti-NMDA receptor encephalitis: diagnosis, psychiatric presentation, and treatment
Chapman, M. R., & Vause, H. E. (2011) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2010.10020181 · Cited by 167
Geschwind, M. D., Haman, A., & Miller, B. L. (2007) · Neurologic Clinics · doi:10.1016/j.ncl.2007.04.001 · Cited by 143
Psychiatric Manifestations of Paraneoplastic Disorders
Kayser, M. S., Kohler, C. G., & Dalmau, J. (2010) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2010.09101547 · Cited by 129
Metadata
- Authors
- Gultekin, S. H.
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2000-07-01
- Volume
- 123
- Issue
- 7
- Pages
- 1481-1494
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- OpenAlex
- W2143285990
- Cited by
- 1,123
- References
- 42
- FWCI
- 15.58
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.